Effects of Survivorship Care Plans on patient reported outcomes in ovarian cancer during 2-year follow-up - The ROGY care trial

Effects of Survivorship Care Plans on patient reported outcomes in ovarian cancer during 2-year follow-up - The ROGY care trial
复制标题

DOI:
10.1016/j.ygyno.2017.02.041
复制
发表时间:
2017-05-01
影响因子:
4.7
通讯作者:
van de Poll-Franse, Lonneke V.
van de Poll-Franse, Lonneke V.
中科院分区:
医学2区
文献类型:
--
作者:
de Rooij, Belle H.;Ezendam, Nicole P. M.;van de Poll-Franse, Lonneke V.

文献摘要

被引文献

相似文献

Objective.本研究的目的是评估在常规临床实践中自动生成的生存护理计划(SCP)对卵巢癌患者报告结局的长期影响。结果的措施包括满意度的信息提供和护理,疾病的看法和卫生保健利用。在这项实用的随机分组试验中,荷兰南部的12家医院被随机分配到“SCP护理”或“常规护理”。所有新诊断的卵巢癌患者在“SCP护理”手臂收到一个SCP,这是自动生成的肿瘤提供者,通过点击一个按钮,在基于Web的注册系统肿瘤妇科(ROGY)。卵巢癌患者(N = 174,平均年龄63.3,SD = 11.4;所有阶段)在初始治疗后直接完成问卷调查,并在6,12和24个月后完成问卷调查。第一份问卷是从“SCP护理”组的61名(67%)卵巢癌患者和“常规护理”组的113名(72%)患者中返回的。在“SCP护理”组中,66%(N = 41)的患者报告接受了SCP。在对信息提供的满意度、对护理或医疗保健利用的满意度方面,未观察到试验组之间的总体差异。在疾病认知方面,“SCP护理”组患者对治疗有助于治愈疾病的信念较低(总体为6.7 vs. 7.5,P < 0.01)。SCP并没有增加卵巢癌患者对信息提供或护理的满意度。我们的试验结果表明,卵巢癌患者可能不会从SCP中获益。(C)2017爱思唯尔公司All rights reserved.
Objective. The aim of this study was to assess the long-term impact of an automatically generated Survivorship Care Plan (SCP) on patient reported outcomes in ovarian cancer in routine clinical practice. Outcome measures included satisfaction with information provision and care, illness perceptions and health care utilization.Methods. In this pragmatic cluster randomized trial, twelve hospitals in the South of the Netherlands were randomized to 'SCP care' or 'usual care'. All newly diagnosed ovarian cancer patients in the 'SCP care' arm received an SCP that was automatically generated by the oncology provider, by clicking a button in the web based Registrationsystem Oncological GYnecology (ROGY). Ovarian cancer patients (N = 174, mean age 63.3, SD = 11.4; all stages) completed questionnaires directly after initial treatment and after 6, 12 and 24 months.Results. First questionnaires were returned from 61 (67%) ovarian cancer patients in the 'SCP care' arm and 113 (72%) patients in the 'usual care' arm. In the `SCP care' arm, 66% (N = 41) of the patients reported receipt of an SCP. No overall differences were observed between the trial arms on satisfaction with information provision, satisfaction with care or health care utilization. Regarding illness perceptions, patients in the 'SCP care' arm had lower beliefs that the treatment would help to cure their disease (overall, 6.7 vs. 7.5, P < 0.01).Conclusions. SCPs did not increase satisfaction with information provision or care in ovarian cancer patients. Our trial results suggest that ovarian cancer patients may not benefit from an SCP. (C) 2017 Elsevier Inc. All rights reserved.